Teniposide is a chemotherapy drug used in the treatment of various types of cancer, including acute lymphoblastic leukemia, non-Hodgkin's lymphoma, and testicular cancer. It is a semi-synthetic derivative of podophyllotoxin, a natural compound found in the roots of the American Mayapple plant. Teniposide works by inhibiting DNA synthesis and inducing cell death. It is administered intravenously over a period of one to four hours. Common side effects of teniposide include nausea, vomiting, hair loss, diarrhea, fatigue, and mouth sores.
Teniposide is a chemotherapy medication used to treat certain cancers, particularly in children. Here's a breakdown of its key aspects:
What it treats:
- Primarily used for treating refractory childhood acute lymphocytic leukemia (ALL) - a type of cancer affecting white blood cells [1, 2].
- In some regions, it's also approved for Hodgkin's lymphoma, some brain tumors, and other cancers [1].
How it works:
- Belongs to a class of drugs called podophyllotoxin derivatives [1].
- Targets and disrupts DNA replication during cell division by inhibiting an enzyme called topoisomerase II [2, 4].
- This disrupts cancer cell growth and leads to cell death [2].
Administration:
- Teniposide is administered intravenously (through a vein) in a hospital setting by a qualified healthcare professional [3].
Important Safety Information:
- Teniposide can significantly lower blood cell count, increasing the risk of infections and bleeding [3].
- It has other potential side effects, so consulting a doctor about potential risks and benefits is crucial before receiving this medication [2, 3].
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01C - Plant alkaloids and other natural products
L01CB Podophyllotoxin derivatives
ATC Code
External Links
Teniposide